The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

A new report suggests a noninvasive means to evaluate portal hypertension in patients with BCR::ABL1-negative ...

A meta-analysis suggests allogeneic stem cell transplantation (allo-SCT) should not be recommended following first-line ...

Defining "value" in cancer care goes beyond survival and should encompass patient quality of life metrics, said Coral Omene, MD, PhD, of Robert Wood Johnson Medical School.